Understanding how tau and ApoE4 affect brain cell health in Alzheimer's disease

Investigating tau and ApoE4-mediated alterations in oligodendrocyte progenitor cells

NIH-funded research Mayo Clinic Jacksonville · NIH-10797003

This study is looking at how a protein called tau and a gene known as ApoE4 affect special brain cells that help keep your brain's protective covering healthy, especially in people with early signs of Alzheimer's, to better understand the disease and find new ways to help.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Jacksonville NIH-funded
Lab location1 site (Jacksonville, United States)
Project IDNIH-10797003 on NIH RePORTER

What this research studies

This research investigates the role of tau protein and the ApoE4 gene in the health of oligodendrocyte progenitor cells, which are crucial for maintaining myelin in the brain. The study aims to uncover how these factors contribute to the demyelination observed in Alzheimer's disease, particularly in patients with mild cognitive impairment. By analyzing changes in these brain cells, the research seeks to provide insights into the mechanisms of Alzheimer's and identify potential therapeutic targets. Patients may be involved in assessments that help correlate genetic factors with brain health.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with mild cognitive impairment or those at risk for Alzheimer's disease, particularly carriers of the ApoE4 genotype.

Not a fit: Patients with advanced Alzheimer's disease or those without cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting oligodendrocyte health.

How similar studies have performed: Previous research has shown promising results in understanding the role of tau and ApoE4 in Alzheimer's, but this specific focus on oligodendrocyte progenitor cells is relatively novel.

Where this research is happening

Jacksonville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Diseaseamyloid disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.